Federal award
SEBIA, INC.
W81K0018P0382
Contract
Obligated and Ceiling
- Obligated (net)
- $79,086.70
- Ceiling (potential value, not spending)
- $1,392,082.60
- Current value
- $1,392,082.60
- Gross positive obligations
- $357,851.60
Obligated is what the government has committed, net of de-obligations. The ceiling is the most the award or vehicle could ever reach; it is shown separately and never added to, or compared as, spending.
Award Details
- Recipient
- SEBIA, INC. · WKVRJJ6G6VB5
- Owner company
- Not a reviewed companyNo reviewed company owns this recipient.
- Reported parent
- SEBIA, INC. · WKVRJJ6G6VB5
- Awarding agency
- Department of War · sub-agency 2100 · office W81K00
- Funding agency
- Department of War · sub-agency 2100
- Product or service (PSC)
- 6550 · IN VITRO DIAGNOSTIC SUBSTANCES, REAGENTS, TEST KITS AND SETS
- Industry (NAICS)
- 325413 · IN-VITRO DIAGNOSTIC SUBSTANCE MANUFACTURING
- PIID
- W81K0018P0382
- Award type code
- B
- Actions
- 13 · Jul 11, 2018 to Jun 18, 2024
- Why it is listed
- gross positive obligations of $100k or more (contracts)
Action History13
| Date | FY | Mod | Action type | Obligation | Company in company totals |
|---|---|---|---|---|---|
| Jun 18, 2024 | FY2024 | P00012 | C | −$278,764.90 | — |
| Oct 28, 2022 | FY2023 | P00011 | C | $357,851.60 | — |
| Jul 25, 2022 | FY2022 | P00010 | G | $0.00 | — |
| Jan 24, 2022 | FY2022 | P00009 | M | $0.00 | — |
| Nov 3, 2021 | FY2022 | P00008 | C | $0.00 | — |
| Jul 20, 2021 | FY2021 | P00007 | G | $0.00 | — |
| Nov 19, 2020 | FY2021 | P00006 | M | $0.00 | — |
| Nov 17, 2020 | FY2021 | P00005 | C | $0.00 | — |
| Jul 28, 2020 | FY2020 | P00004 | G | $0.00 | — |
| Nov 29, 2019 | FY2020 | P00003 | C | $0.00 | — |
| Jun 7, 2019 | FY2019 | P00002 | G | $0.00 | — |
| Nov 5, 2018 | FY2019 | P00001 | M | $0.00 | — |
| Jul 11, 2018 | FY2018 | 0 | — | $0.00 | — |
Newest first. Every obligation is shown as reported, including zero and negative (de-obligation) actions. Award lists belong to the company of the latest action; company totals credit each action to the company named on that row, so a note marks rows where the two differ.